phosfolan has been researched along with Colorectal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, K; Arai, Y; Arihiro, S; Homma, S; Nagata, Y; Nishimura, T; Noguchi, M; Sagawa, Y; Saruta, M; Sawada, R | 1 |
1 other study(ies) available for phosfolan and Colorectal Neoplasms
| Article | Year |
|---|---|
High blood levels of soluble OX40 (CD134), an immune costimulatory molecule, indicate reduced survival in patients with advanced colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Tumor-Associated, Carbohydrate; C-Reactive Protein; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Jurkat Cells; Male; Middle Aged; Neoplasm Staging; Organothiophosphorus Compounds; Receptors, OX40; Serum Albumin, Human; Survival Analysis; Up-Regulation | 2019 |